Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Disease Specific Protein Corona Publisher



Rahman M1, 2 ; Mahmoudi M1, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Nanotechnology, Nanotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Chemical Engineering and Materials Science, University of California, Davis, 95616, CA, United States
  3. 3. Division of Cardiovascular Medicine, Stanford School of Medicine, 94305, CA, United States

Source: Progress in Biomedical Optics and Imaging - Proceedings of SPIE Published:2015


Abstract

It is now well accepted that upon their entrance into the biological environments, the surface of nanomaterials would be covered by various biomacromolecules (e.g., proteins and lipids). The absorption of these biomolecules, so called 'protein corona', onto the surface of (nano)biomaterials confers them a new 'biological identity'. Although the formation of protein coronas on the surface of nanoparticles has been widely investigated, there are few reports on the effect of various diseases on the biological identity of nanoparticles. As the type of diseases may tremendously changes the composition of the protein source (e.g., human plasma/serum), one can expect that amount and composition of associated proteins in the corona composition may be varied, in disease type manner. Here, we show that corona coated silica and polystyrene nanoparticles (after interaction with in the plasma of the healthy individuals) could induce unfolding of fibrinogen, which promotes release of the inflammatory cytokines. However, no considerable releases of inflammatory cytokines were observed for corona coated graphene sheets. In contrast, the obtained corona coated silica and polystyrene nanoparticles from the hypofibrinogenemia patients could not induce inflammatory cytokine release where graphene sheets do. Therefore, one can expect that disease-specific protein coronas can provide a novel approach for applying nanomedicine to personalized medicine, improving diagnosis and treatment of different diseases tailored to the specific conditions and circumstances. © 2015 SPIE.
Other Related Docs
9. Nanoparticles and Biological Environment Interactions, Advanced Structured Materials (2019)
10. Protein Corona: Opportunities and Challenges, International Journal of Biochemistry and Cell Biology (2016)
17. Misinterpretation in Nanotoxicology: A Personal Perspective, Chemical Research in Toxicology (2016)
18. Biomolecular Corona Dictates Aβ Fibrillation Process, ACS Chemical Neuroscience (2018)
26. Dual Nano-Sized Contrast Agents in Pet/Mri: A Systematic Review, Contrast Media and Molecular Imaging (2016)
37. Toxicity and Biocompatibility of Nanomaterials: In Vivo Studies, Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial Resistance (2022)
40. Smart Internal Stimulus-Responsive Nanocarriers for Drug and Gene Delivery, Smart internal stimulus-responsive nanocarriers for drug and gene delivery (2015)
42. Smart External Stimulus-Responsive Nanocarriers for Drug and Gene Delivery, Smart External Stimulus-Responsive Nanocarriers for Drug and Gene Delivery (2015)
47. Protein Corona: Challenges and Opportunities for Cancer Therapy, Functionalized Nanomaterials for Cancer Research: Applications in Treatments# Tools and Devices (2024)
49. Toxicity of Inorganic Nanoparticles, Comprehensive Analytical Chemistry (2022)